Bicycle Therapeutics PLC SEC filings BCYC

Bicycle Therapeutics PLC has 660 filings in SEC EDGAR's recent list, going back to Dec 21, 2018. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Bicycle Therapeutics PLC SEC filings
Form Description Filed Period
ARS Annual report to shareholders Apr 22, 2026 Dec 31, 2025
10-K Annual report Mar 17, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 23, 2025 Dec 31, 2024
10-K Annual report Feb 25, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 15, 2024 Dec 31, 2023
10-K Annual report Feb 20, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
10-K Annual report Feb 28, 2023 Dec 31, 2022
10-K Annual report Mar 1, 2022 Dec 31, 2021
10-K Annual report Mar 11, 2021 Dec 31, 2020
10-K Annual report Mar 10, 2020 Dec 31, 2019

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BCYC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
United Kingdom
Headquarters
Cambridge, United Kingdom
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1761612
Former names
BICYCLE THERAPEUTICS Ltd (until May 24, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.